Presence of vascular anomalies with congenital hemihypertrophy and wilms tumor: An evidence-based evaluation

Pediatric Dermatology

Volumn 20, Issue 3, 2003, Pages 199-206

  Kundu, Roopal V ^a,c   Frieden, Ilona J ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOOSTEOHYPERTROPHY SYNDROME; CHILDHOOD CANCER; CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE ASSOCIATION; DISEASE COURSE; EVIDENCE BASED MEDICINE; HEMANGIOMA; HEMIHYPERTROPHY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; PRIORITY JOURNAL; REVIEW;

ABNORMALITIES, MULTIPLE; BECKWITH-WIEDEMANN SYNDROME; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; COMORBIDITY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTROPHY; INCIDENCE; INFANT, NEWBORN; KIDNEY NEOPLASMS; MALE; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; WILMS TUMOR;

EID: 0038648607     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.2003.20303.x     Document Type: Review

References (73)

1. Meckel JF. Ueber die seitliche Asymmetrie im tierischen Korper. Anatomische physiologische Beobachtungen und Untersuchungen. Halle: Renger, 1822:147.
2. Miller RW, Fraumeni JF, Manning MD. Association of Wilms's tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 1964;270:922-927.
3. Clericuzio CL. Clinical phenotypes and Wilms tumor. Med Pediatr Oncol 1993;21:182-187.
4. Ballock RT, Wiesner GL, Myers MT, Thompson GH. Hemihypertrophy. Concepts and controversies. J Bone Joint Surg Am 1997;79:1731-1738.
5. Wiedemann H. Tumors and hemihypertrophy associated with the Wiedemann-Beckwith syndrome. Eur J Pediatr 1983;141:129.
6. Cohen MM. Asymmetry: molecular, biologic, embryopathic, and clinical perspectives. Am J Med Genet 2001; 101:292-314.
7. Cohen MM. Overgrowth syndromes: an update. Adv Pediatr 1999;46:441-491.
8. Hoyme HE, Seaver LH, Jones KL, Procopio F, Crooks W, Feingold M. Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 1998;79: 274-278.
9. Beals RK. Hemihypertrophy and hemihypotrophy. Clin Orthop 1982;166:199-203.
10. Shekelle PG, Morton SC. Principles of metaanalysis. J Rheumatol 2000;27:251-252.
11. Lycka BAS. Meta-analysis for dermatologists. Int J Dermatol 1990;29:229-231.
12. Williams H, Adetugbo K, Po AL, Naldi L, Diepgen T, Murrell D. The Cochrane Skin Group: preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology. Arch Dermatol 1998;134: 1620-1626.
13. Bjorklund SI. Hemihypertrophy and Wilms's tumour. Acta Paediatr 1955;44:287-292.
14. Benson PF, Vulliamy DG, Taubman JO. Congenital hemihypertrophy and malignancy. Lancet 1963;1:468-469.
15. Wilson FC Jr, Orlin H. Crossed congenital hemihypertrophy associated with a Wilms' tumor: report of a case. J Bone Joint Surg Am 1965;47:1609-1614.
16. Fraumeni JF Jr, Geiser CF, Manning MD. Wilms' tumor and congenital hemihypertrophy: report of five new cases and review of literature. Pediatrics 1967;40:886-899.
17. Boxer LA, Smith DL. Wilms' tumor prior to onset of hemihypertrophy. Am J Dis Child 1970;120:564-565.
18. Mankand VN, Gray GF, Miller DR. Bilateral nephroblastomatosis and Klippel Trenaunay syndrome. Cancer 1974;33:1462-1467.
19. Pfister RC, Weber AL, Smith EH, Wilkinson RH, May DA. Congenital asymmetry (hemihypertrophy) and abdominal disease: radiological features in 9 cases. Radiology 1975;116:685-691.
20. Pendergrass TW. Congenital anomalies in children with Wilms' tumor: a new survey. Cancer 1976;37:403-409.
21. Brantley RE, Simson LR Jr. Angiography and histopathology of nephroblastomatosis. Radiology 1976;120:151-154.
22. Muller S, Gadner H, Weber B, Vogel M, Riehm H. Wilms' tumor and adrenocortical carcinoma with hemihypertrophy and hamartomas. Eur J Pediatr 1978;127:219-226.
23. Maurer HS, Pendergrass TW, Borges W, Honig GR. The role of genetic factors in the etiology of Wilms' tumor: two pairs of monozygous twins with congenital abnormalities (aniridia; hemihypertrophy) and discordance for Wilms' tumor. Cancer 1979;43:205-208.
24. Ehrich JH, Ostertag H, Flatz S, Kamran D. Bilateral Wilms's tumour in Klippel-Trenaunay syndrome. Arch Dis Child 1979;54:405.
25. Onyango FE. Bilateral Wilms' tumour with hemihypertrophy: a case report. East Afr Med J 1983;60:809-813.
26. Nakagome Y, Ise T, Sakurai M, et al. High-resolution studies in patients with aniridia-Wilms tumor association, Wilms tumor or related congenital abnormalities. Hum Genet 1984;67:245-248.
27. Bishop HC, Betts J, Chatten J. Partial nephrectomy for Wilms' tumor in a child with hemihypertrophy. Med Pediatr Oncol 1985;13:37-39.
28. Gupta S, Meena HS, Chopra R, Jain S, Bidani R. Congenital hemihypertrophy: report of four cases. J Assoc Physicians India 1991;39:494-497.
29. Sarkar S, Prakash D, Marwaha RK, Samujh R, Rao KL. Congenital hemihypertrophy and Wilms' tumor. Indian Pediatr 1992;29:1160-1162.
30. Bonaiti-Pellie C, Chompret A, Tournade MF, et al. Genetics and epidemiology of Wilms' tumor: the French Wilms' tumor study. Med Pediatr Oncol 1992;20:284-291.
31. Stalens JP, Maton P, Gosseye S, Clapuyt P, Ninane J. Hemihypertrophy, bilateral Wilms' tumor, and clear-cell adenocarcinoma of the uterine cervix in a young girl. Med Pediatr Oncol 1993;21:671-665.
32. Stoll C, Alembik Y, Steib JP, DeSaint-Martin A. Twelve cases with hemihypertrophy: etiology and follow up. Genet Couns 1993;4:119-126.
33. Yeo EE, Low JC. Scintigraphic finding of crossed hemihypertrophy in association with Wilms' tumor. Clin Nucl Med 1993;18:247-248.
34. Kumar M, Pratt CB, Coburn TP, Johnson WW. Treatment strategy for nodular renal blastema and nephroblastomatosis associated with Wilms' tumor. J Pediatr Surg 1978;13:281-285.
35. Hennessy WT, Cromie WJ, Duckett JW. Congenital hemihypertrophy and associated abdominal lesions. Urology 1981;18:576-579.
36. Burchfield D, Escobar V. Familial facial asymmetry (autosomal dominant hemihypertrophy?). Oral Surg Oral Med Oral Pathol 1980;50:321-324.
37. Furukawa T, Shinohara T. Congenital hemihypertrophy: oncogenic potential of the hypertrophic side. Ann Neurol 1981;10:199-201.
38. Geormaneanu M, Iagaru N, Popescu-Miclosanu S, Badulescu M. Congenital hemihypertrophy. Tendency to association with other abnormalities and/or tumors. Morph Embryol 1983;29:39-45.
39. Gerloczy F, Schuler D. Hemihypertrophy: incidence and chromosomal examinations. Acta Paediatr Acad Sci Hung 1968;9:323-328.
40. Hanley FJ, Floyd CE, Parker D. Congenital partial hemihypertrophy of the face. Report of three cases. J Oral Surg 1968;26:136-141.
41. MacEwen GD, Case JL. Congenital hemihypertrophy. A review of 32 cases. Clin Orthop 1967;50:147-150.
42. Nudleman K, Andermann E, Andermann F, Bertrand G, Rogala E. The hemi 3 syndrome: hemihypertrophy, hemihypaesthesia, hemiareflexia and scoliosis. Brain 1984;107:533-546.
43. Viljoen D, Pearn J, Beighton P. Manifestations and natural history of idiopathic hemihypertrophy: a review of eleven cases. Clin Genet 1984;26:81-86.
44. Woon KY, Tan L, Tan KL. Congenital hemihypertrophy: a report of seven cases. J Singapore Paediatr Soc 1978; 20:103-109.
45. Schofield D, Cotran RS. Diseases of infancy and childhood. In: Robbins SL, Cotran RS, Kumar V, eds. Robbins pathologic basis of disease, 6th ed. Philadelphia: WB Saunders, 1999:488.
46. Anderson PM. Neoplasms of the kidney. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics, 16th ed. Philadelphia: WB Saunders, 2000:556.
47. Imperiale TF. Meta-analysis: when and how. Hepatology 1999;29(suppl 6):S26-S31.
48. Meine JG, Schwartz RA, Janniger CK. Klippel Trenaunay-Weber syndrome. Cutis 1997;60:127-132.
49. Berry SA, Peterson C, Mize W, et al. Klippel-Trenaunay syndrome. Am J Med Genet 1998;79:319-326.
50. Samuel M, Spitz L. Klippel-Trenaunay syndrome: clinical features, complications and management in children. Br J Surg 1995;82:757-761.
51. Young AE. Combined vascular malformations. In: Mulliken JB, Young AE, eds. Vascular birthmarks. Hemangiomas and Malformations. Philadelphia: WB Saunders, 1988.
52. Samlaska CP, Levin SW, James WD, Benson PM, Walker JC, Perlik PC. Proteus syndrome. Arch Dermatol 1989; 125:1109-1114.
53. Gordon PL, Wilroy RS, Lasater OE, Cohen MM Jr. Neoplasms in Proteus syndrome. Am J Med Genet 1995;57:74-78.
54. Biesecker LG, Happle R, Mulliken JB, et al. Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet 1999;84:389-395.
55. Sotos JF. Overgrowth. Section VI. Genetic syndromes and other disorders associated with overgrowth. Clin Pediatr 1997;36:157-170.
56. Elliott M, Maher ER. Beckwith-Wiedemann syndrome. J Med Genet 1994;31:560-564.
57. Debaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002;70:604-611.
58. Dome JS, Coppes MJ. Recent advances in Wilms tumor genetics. Curr Opin Pediatr 2002;14:5-11.
59. Weng EY, Mortier GR, Graham JM Jr. BeckwithWiedemann syndrome. An update and review for the primary pediatrician. Clin Pediatr 1995;34:317-326.
60. South DA, Jacobs AH. Cutis marmorata telangiectatica congenita (congenital generalized phlebectasia). J Pediatr 1978;93:944-949.
61. Picascia DD, Esterly NB. Cutis marmorata telangiectatica congenita: report of 22 cases. J Am Acad Dermatol 1989;20:1098-1104.
62. Gerritsen MJP, Steijlen PM, Brunner HG, Rieu P. Cutis marmorata telangiectatica congenita: report of 18 cases. Br J Dermatol 2000;142:366-369.
63. Way BH, Herrmann J, Gilbert EF, Johnson SA, Opitz JM. Cutis marmorata telangiectatica congenita. J Cutan Pathol 1974;1:10-25.
64. Clayton-Smith J, Kerr B, Brunner H, et al. Macrocephaly with cutis marmorata, haemangioma and syndactyly - a distinctive over-growth syndrome. Clin Dysmorphol 1997;6:291-302.
65. Moore CA, Toriello HV, Abuelo DN, etal. Macrocephalycutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities. Am J Med Genet 1997;70:67-73.
66. Robertson SP, Gattas M, Rogers M, Ades LC. Macrocephaly-cutis marmorata telangiectatica congenita: report of five patients and a review of the literature. Clin Dysmorphol 2000;9:1-9.
67. Knudson AG Jr, Strong LC. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst 1972;48:313-324.
68. Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res 2001;264:74-99.
69. Koesters R, Ridder R, Kopp-Schneider A, et al. Mutational activation of the β-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 1999;59:3880-3882.
70. Reeve AE, Sih SA, Raizis AM, Feinberg AP. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol 1985;9:1799-1803.
71. Sheng WW, Soukup S, Bove K, Gotwals B, Lampkin B. Chromosomal analysis of 31 Wilms' tumors. Cancer Res 1990;50:2786-2793.
72. Maw MA, Grundy PE, Millow LJ, et al. A third Wilms' tumor locus on chromosome 16q. Cancer Res 1992; 52:3094-3098.
73. Grundy RG, Pritchard J, Scambler P, Cowell JK. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour. Oncogene 1998;17:395-400.